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Introduction
Alcohol exposure is one of the leading risk factors for popula-
tion health worldwide, and as a known toxin and teratogen, it 
has a direct impact on maternal and child health.1 There is a 
body of evidence demonstrating that prenatal alcohol exposure 
(PAE) can profoundly affect the foetus and result in a myriad 
of lifelong physical and cognitive disabilities, known interna-
tionally as foetal alcohol spectrum disorders (FASDs).2 Foetal 
alcohol spectrum disorder is an umbrella term that encom-
passes several medical diagnoses, from the complete presenta-
tion of foetal alcohol syndrome (FAS), to a range of conditions 
– including partial foetal alcohol syndrome (pFAS), alcohol-
related birth defects (ARBDs), alcohol-related neurodevelop-
mental disorders (ARNDs), and neurobehavioral disorder 
associated with prenatal alcohol exposure (ND-PAE). These 
diagnostic terms demonstrate various features of FASD and 
facilitate appropriate interventions in the patient pathway. For 
clarity, the term FASD will be used in this article. In the United 
Kingdom, FASD has recently become increasingly prominent 
within the public health agenda, as awareness of the condition 
slowly improves.3 The Chief Medical Officers for the United 
Kingdom recommend that pregnant women, or those planning 
to become pregnant, avoid drinking any alcohol at all to keep 
risks to a minimum.4 Screening for alcohol use early in preg-
nancy will facilitate the identification of those in need of sup-
port to discontinue or reduce their alcohol consumption.5 
Furthermore, screening of the mother during pregnancy, and 
later of the neonate, may enable infants exposed to alcohol to 
be identified and diagnosed.6 In the United Kingdom, women 
of child-bearing age are some of the highest consumers of 
alcohol.7 Popova et al8 recently estimated that 41.3% of women 
in the United Kingdom consume alcohol during pregnancy, 
corroborating findings by the UK Infant Feeding Survey, 
where two in five mothers admitted drinking alcohol during 
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pregnancy.9 This compares to a global estimated average of 
10%, but Western societies which traditionally have a stronger 
alcohol culture were understandably found to have higher 
prevalence rates including the United States, estimated at 20% 
to 30%.8 The UK National Institute for Heath and Care 
Excellence (NICE)10 specifies the importance of screening as 
part of antenatal care, recommending that women should be 
given information about all issues including alcohol that may 
affect their health or the health of their baby. To optimise the 
health and well-being of women and their children, the World 
Health Organization (WHO) state that screening is a priority 
to prevent, reduce, and stop the use of alcohol during preg-
nancy and the postpartum period.1
After the child is born, the early diagnosis of FASD facili-
tates opportunities for early intervention and management for 
the affected child and reduces rates of secondary disabilities, 
such as mental health problems and exclusion from school.11 It 
also helps reduce the risk of future PAE pregnancies.
As the first point of contact, physicians and other health 
care professionals are in a position to fulfil a crucial role in the 
prevention and identification of FASD. Appropriate screening 
for prenatal alcohol use should be prioritised in clinical prac-
tice, as eliminating or decreasing alcohol consumption at any 
point in pregnancy will reduce the risk of harm to the foetus.12 
The effectiveness of brief interventions are well documented, 
and even the process of screening has been shown to raise 
awareness and may reduce alcohol consumption in pregnancy.2 
It is, therefore, important to consider the knowledge and atti-
tudes of health care professionals regarding alcohol because a 
lack of understanding of the issues will limit opportunities for 
FASD prevention, diagnosis, and early intervention.13 Several 
international studies involving doctors and midwives have 
demonstrated confusion around the appropriate advice to give 
to pregnant women on the use of alcohol in pregnancy and the 
effects of alcohol on the foetus. Payne et al14 surveyed 166 mid-
wives across Western Australia and reported that 93.2% said 
that they ask about alcohol consumption in accordance with 
the national guidelines which advocate that not drinking is the 
safest option in pregnancy. In addition, 64.2% stated that they 
informed women of the effects of PAE, 47.5% did not always 
use the recommended Alcohol Use Disorders Identification 
Test (AUDIT; a simple screening tool developed by WHO to 
pick up the early signs of hazardous and harmful drinking and 
identify mild dependence), and 70.4% admitted to not provid-
ing brief interventions. Diekman et  al15 surveyed 600 US 
obstetrician-gynaecologists and found that although 97% 
reported asking patients about alcohol consumption, only 20% 
would advise abstinence as the safest option in pregnancy, 13% 
were unsure about harmful levels, and 4% believed that eight or 
more drinks per week would not increase the risk of adverse 
outcomes. Some studies have identified the provision of vague 
advice regarding drinking alcohol in pregnancy, recommending 
‘cutting down’ rather than ‘giving up’ alcohol.12,16,17 It has been 
suggested that conflicting official British national health and 
professional organisations and even international advice has 
confused the issue for health care professionals and women 
alike.18 For example, the lack of conclusive evidence regarding 
the safety of low levels of PAE has contributed to the varying 
guidelines and advice on alcohol consumption during 
pregnancy.
Thousands of families are currently seeking an FASD diag-
nosis for their children and have voiced their concerns over the 
lack of services available.19 The FASD Network United 
Kingdom has requested this research to raise awareness with 
health care professionals to help address this important issue.20
The level of FASD knowledge among professionals is a 
documented factor that influences the rates of diagnosis.21,22 
The literature reports that paediatricians under-report FASD 
and even misdiagnose the condition as other medical condi-
tions such as attention deficit hyperactivity disorder, due to 
stigma as well as diagnostic uncertainty.17
Evidence suggests that biomarkers may have clinical value 
in detecting alcohol consumption in pregnancy, to highlight 
women in need of support and later to facilitate diagnosis for 
children affected with FASD.23 Consequently, we were inter-
ested in finding the views of health care professionals around 
obtaining blood or meconium samples to supplement self-
report, given the complex ethical nature of the issue.
The aim of this study was to explore the current perceived 
knowledge, practices, and attitudes of the key health profes-
sionals in the United Kingdom regarding alcohol consumption 
in pregnancy and FASD in childhood. For the purpose of this 
study, we adopted the Oxford Dictionary definition of 
Knowledge ‘Facts, information and skills acquired through 
experience or education; the theoretical or practical under-
standing of a subject’.
It was intended that these findings would help address an 
apparent gap in knowledge when the UK prevalence rate for 
alcohol consumption in pregnancy is the fourth highest in the 
world, and yet most children with FASD-related disabilities 
remain undiagnosed and therefore, unsupported. We intend to 
use the results from this study to highlight the training needs 
of each professional group to provide evidence based recom-
mendations to improve clinical practice.
Ethics
The study received a favourable ethical opinion from the Tyne 
& Wear South National Research Ethics Committee (Ref: 15/
NE/0216). The survey data presented here were provided on a 
voluntary basis and were collected anonymously using an 
online survey.
Methods
This was a cross-sectional online survey conducted between 
October 2015 and July 2016.
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Key professional groups were sent a web-link to the survey 
via email. We used a pragmatic cascade method of distribution 
to maximise the number of potential respondents, making the 
exact figures approached unknown. An introductory summary 
contained information about the study aims and how the data 
would be used. The contact details of the lead midwife (H.H.) 
were also given in case respondents required more information 
before completing the form. Given the nature of data collec-
tion, written consent was not obtained from those who com-
pleted the survey. Names and addresses, or any other personal 
identifiable data, were not collected.
Participants
We targeted key health professionals involved in screening for 
alcohol and FASD during antenatal, postnatal, and paediatric 
care. Surveys were sent to midwives, obstetricians, general 
practitioners (GPs), health visitors, and paediatricians. In the 
United Kingdom, the role of the midwife is to provide care and 
support to women during pregnancy, throughout labour, and 
the early postnatal period. The midwife enables women to 
make informed choices about their care and is usually the first 
and main contact. Whereas, health visitors are nurses or mid-
wives who have completed extra training to work with families 
to give pre-school-age children the best possible start in life by 
promoting healthy lifestyles and preventing illness. Contact 
with the family usually begins antenatally with an introductory 
visit at around 32 week’s gestation. An email cascade approach 
was used for distribution using colleagues and contacts at local, 
regional, and national levels. These included the local National 
Health Service (NHS) Trust distribution network and research 
and professional organisations such as the National Institute 
for Health Research Local Clinical Research Network and the 
Institute for Health Visiting. We asked recipients to forward 
the survey links to other colleagues to maximise the number of 
respondents.
Survey questionnaire
The online survey was piloted by representatives from each 
professional group before general circulation and took under 
10 minutes to complete. After feedback, some questions were 
adapted to aid clarification and ensure that the profession-
specific part of the surveys were appropriate. No data from the 
pilot phase were included in the final results because we did 
not want to compromise the accuracy and consistency of the 
results. Health care professionals were asked general questions 
around alcohol in pregnancy and FASD in the first part of the 
questionnaire, and the later questions were adapted to the spe-
cific role of each profession. For example, obstetricians and 
midwives were asked about alcohol during pregnancy and 
referring mothers while paediatricians and health visitors 
focussed more on the presentation of the children with FASD 
and retrospective PAE issues. We wanted to gain a greater 
insight into perceived knowledge and confidence levels in all 
professions and learn about a general range of issues around 
alcohol and FASD screening, referral practices, and finally, 
diagnostic experience. The intention was then to identify the 
gaps in perceived knowledge to inform future training provi-
sion. Feedback regarding professional practice in the United 
Kingdom is of particular interest, as the current documented 
lack of service provision poses many challenges to NHS staff.19 
We were guided by the questions asked by the existing inter-
national body of knowledge so that we could augment existing 
data and compare this to our UK sample of respondents. The 
questions were multiple-choice type with additional free text 
to complete where appropriate. The questions can be catego-
rised into three broad areas of clinical practice, knowledge, and 
attitudes, which we acknowledge can overlap. The questions 
are listed in Table 1.
Data analysis
Data analysis was supported by the software package SPSS 
(version 23, IBM Corp, Armonk, NY, USA). Data were sum-
marised using standard summary statistics (eg mean, median, 
and frequency) depending on the type of data collected. We 
employed descriptive statistics to gain in-depth information 
from our respondents. Only valid responses are included. In 
this study, invalid answers referred to unanswered questions, or 
the field was left blank. For three questions, an answer was 
given which did not appear to answer the question. In these 
cases, the answer was deemed invalid. Three researchers 
reviewed the data and came to a consensus regarding valid 
answers. All responses were also verified by the co-authors to 
reduce bias.
Results
There were a total of 250 responses to the surveys: 78 mid-
wives, 60 health visitors, 55 obstetricians, 31 paediatricians, 
and 26 GPs responded during the data collection period 
(10 months).
Clinical practice-related results
Alcohol screening practices in pregnancy. Rates of reported 
screening for alcohol use were generally high (midwives 68/75 
[90.7%], health visitors 51/55 [92.7%], obstetricians 41/55 
[74.5%], although rates were lower in GPs 14/26 [53.8%]). 
However, there was little consistency in the choice of alcohol 
screening tools. The most common approach used by 113 
respondents was simply detailed questioning with no specific 
tool. Five clinicians used AUDIT. Alcohol Use Disorders Iden-
tification Test – C, a shortened version of the AUDIT tool, was 
used by 32 professionals. A total of 18 staff utilised a local 
NHS Trust-specific assessment. Four respondents used TACE 
(a measurement tool of four questions: tolerance, annoyance, 
cut down and eye opener), and two utilised CAGE (four ques-
tions: cut down, annoyance, guilt and eye opener).
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Table 1. Survey questions.
Clinical practice-related questions
1. Do you routinely screen for alcohol consumption in your general consultations?
Yes/No
2. Do you ask about alcohol consumption at antenatal visits?
Yes/No
3. Which assessment tool do you use?
Self-reporting
Audit C
AUDIT
TACE
TWEAK
Don’t ask
Other (please specify)
4. What levels of alcohol consumption would cause you to refer?
Any alcohol if still drinking
>4 units/week
>6 units/week
>14 units/week
>21 units/week
AUDIT C > 4
AUDIT C > 5
AUDIT C > 6
If drunk at appointment
Other (please specify)
5. Who would you refer to?
Never referred
Alcohol specialist nurse/midwife
Obstetric consultant
Addictions service
Social worker/child protection
Non-government organisations, eg Alcoholics Anonymous
Community psychiatric nurse (CPN)/Mental Health Team
Liver/Alcohol medical consultant
Other (please specify)
6. Do you currently screen for foetal alcohol syndrome (FAS)/foetal alcohol spectrum disorder (FASD)?
Yes/No
7. If a child in your care was suspected of having foetal alcohol syndrome (FAS)/foetal alcohol spectrum disorder (FASD), who would you refer 
to?
Paediatrician
Speech therapist
Geneticist
Psychologist
Neurodevelopmental paediatrician
Social worker
Children and adolescents mental health service (CAMHS)
Non-government organisation eg FASD Network UK, NOFAS UK
Never referred
Other (please specify)
Knowledge-related questions
8. How many children are thought to be affected by foetal alcohol syndrome (FAS) in the UK?
1: 100
1: 500
1: 1000
1: 2000
I don’t know
9. How many children are thought to be affected by foetal alcohol spectrum disorder (FASD) in the UK?
1: 100
1: 500
1: 1000
1: 2000
I don’t know
10. How confident do you feel in your knowledge about the prevalence and presentation of foetal alcohol syndrome (FAS)/foetal alcohol 
spectrum disorder (FASD)?
Not confident
Fairly confident
Very confident
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11. Have you received training on asking about alcohol consumption in pregnancy?
Yes/No
12. Would you feel comfortable discussing maternal alcohol consumption during pregnancy if a child in your care demonstrated some foetal 
alcohol syndrome (FAS)/foetal alcohol spectrum disorder (FASD) traits?
Yes/No
13. Have you ever received training in foetal alcohol syndrome (FAS)/foetal alcohol spectrum disorder (FASD)?
Yes/No
14. Do you feel able to recognise signs, symptoms and behaviours associated with foetal alcohol syndrome (FAS)/foetal alcohol spectrum 
disorder (FASD) in infants and children?
Yes/No
15. How confident do you feel in diagnosing foetal alcohol syndrome (FAS)/foetal alcohol spectrum disorder (FASD)?
Not confident
Fairly confident
Very confident
16. Have you ever suspected foetal alcohol syndrome (FAS)/foetal alcohol spectrum disorder (FASD) but did not refer?
Yes/No
17. Have you ever been convinced of a diagnosis but did not record?
Yes/No
18. Do you feel worried about stigmatisation with diagnosis?
Yes/No
19. How many foetal alcohol syndrome (FAS)/foetal alcohol spectrum disorder (FASD) children have you knowingly encountered in your 
career?
1-5
6-10
11-20
21-40
41 +
20. Would you be interested in further training on foetal alcohol syndrome (FAS)/foetal alcohol spectrum disorder (FASD)?
Yes/No
Attitude-related questions
21. To help identify children at risk of foetal alcohol syndrome (FAS)/foetal alcohol spectrum disorder (FASD), do you think pregnant women 
should be routinely screened for alcohol consumption using a blood test during their routine booking bloods?
Yes/No
22. Would you feel comfortable asking permission from pregnant women to screen for alcohol levels with the routine antenatal booking 
bloods?
Yes/No
23. To help identify children at risk of foetal alcohol syndrome (FAS)/foetal alcohol spectrum disorder (FASD), do you think we should 
routinely screen pregnant women for alcohol consumption by testing the first meconium nappy?
Yes/No
24. Would you feel comfortable asking permission from mothers to check for alcohol levels in the first meconium nappy?
Yes/No
Abbreviations: AUDIT, Alcohol Use Disorders Identification Test; TACE, tolerance, annoyance, cut down and eye opener; CAGE, cut down, annoy-
ance, guilt and eye opener.
Table 1. (Continued)
Referral for alcohol use in pregnancy. Reported levels of drinking 
at which midwives would refer varied considerably: 32/75 
(43.2%) specified they would refer for any reported alcohol 
consumption, 10 (13.5%) stated they would refer if drinking 
more than 14 units of alcohol per week and 8 (10.8%) if more 
than 21 units per week. A further 11 (14.9%) indicated they 
would only refer if the patient was visibly drunk at an appoint-
ment. Responses from health visitors were similar: 26/53 
(49.1%) indicated they would refer if any drinking was reported, 
6 (11.3%) if greater than 14 units per week and 4 (7.5%) is 
greater than 21 units per week, 3 (5.7%) said they would only 
refer if the patient was visibly drunk when seen.
Of 51 midwives who answered that they had referred some-
one for alcohol use in pregnancy, 36 (70.6%) had referred to an 
alcohol specialist nurse and 42 (82.4%) to an obstetrician, 16 
(31.4%) to addiction services and 18 (35.3%) to a social worker 
or child protection officer. Of 32 health visitors who had 
referred someone for alcohol use in pregnancy, 28 (87.5%) had 
referred to an alcohol specialist nurse, 4 (12.5%) to an obstetri-
cian, 11 (34.4%) to addiction services, and 12 (37.5%) to a 
social worker.
Only 5/25 GPs responded that they would refer for any 
alcohol consumption in pregnancy, 8 if consumption was 
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greater than 14 units per week, and 5 if greater than 21 units 
per week: 8 specified they would refer if the patient was visibly 
drunk when seen.
Referral for FASD. The numbers of known children with FASD 
were very low, with five or fewer was the most common response 
even among paediatricians. Of the 31 paediatricians in the 
study, 18 (58.1%) had diagnosed a patient with FASD. How-
ever, 11/30 (36.7%) said they worried about stigmatisation with 
diagnosis and, of these, 2 said they had been convinced of a 
diagnosis but did not refer to more specialist services.
51/55 (92.7%) health visitors said they would refer an infant 
with FASD to a paediatrician or neurodevelopmental paedia-
trician, and 36 (65.5%) would refer to the GP and 12 (21.8%) 
to a social worker. All 24 GPs respondents said they would 
refer to a paediatrician or neurodevelopmental paediatrician, 
and 3 said they would refer to a social worker.
Knowledge-related results
Training in screening for alcohol use in pregnancy and identifying 
FASD in infants. Rates of previous training in FAS and FASD 
(Figure 1) were generally low, with midwives and GPs having 
the lowest rates of previous training and health visitors the 
highest rates. This was corroborated with a high level of 
requests for further training across the specialities, ranging 
from 98% of health visitors to two-thirds of GPs. Online train-
ing packages were requested by some respondents because they 
can be easily accessed at a time and place to suit.
Perceived knowledge of FASD. The lack of training was reflected 
in low levels of knowledge about the prevalence of FAS and 
FASD in the general population. Overall, only 22.1% of 
respondents knew the estimated prevalence of FAS and only 
19.8% the estimated prevalence of FASD (Figure 2).
Discussing FASD with parents. Health visitors, paediatricians, 
and GPs were asked how comfortable they would feel discuss-
ing FASD with a parent; 38/60 (63.3%) of health visitors, 
24/30 (80.0%) paediatricians, and 23/25 (92.0%) GPs said they 
would feel comfortable.
Signs, symptoms, and diagnosis. A total of 17 from 74 (23.0%) 
midwives said they would feel confident (1 very confident and 
16 fairly confident) in identifying the signs and symptoms of 
FASD, whereas 11/55 (20.0%) health visitors and only 1 (3.8%) 
GP said they would feel confident (all fairly confident). Confi-
dence was higher in paediatricians (64.5%, 15 fairly confident 
and 5 very confident) and obstetricians (34.5%, 18 fairly confi-
dent and 1 very confident).
A total of 18 (58.1%) paediatricians had previously diagnosed 
FASD, although only 3 (9.7%) claimed to be very confident and 
14 (45.2%) fairly confident about diagnosing FASD. In contrast, 
only one (3.8%) GP disclosed they had ever diagnosed FASD 
before, two (7.7%) said they would be fairly confident about 
diagnosing; none stated they would be very confident.
Attitude-related results
Attitudes to blood and meconium screening. As blood and meco-
nium screening has the potential to detect alcohol consump-
tion in pregnancy and supplement self-report, professionals 
opinions were sought on the feasibility of both in practice. 
Figure 1. Previous training and need for further training.
Figure 2. Knowledge of the prevalence of FAS and FASD.
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General practitioners (64.0% and 70.8%, respectively) and 
health visitors (74.6% and 63.8%, respectively) were much 
stronger advocates than midwives (56.4% and 41.6%, respec-
tively), obstetricians (45.5% and 43.6%, respectively), or pae-
diatricians (40.0% and 35.7%, respectively).
Discussion
The results of this study gives us a greater understanding of the 
perceived knowledge, attitudes, and clinical practices of the key 
health care professionals delivering care throughout the patient 
journey from the antenatal period and throughout childhood. 
This included the identification and referral of women who 
drink alcohol in pregnancy and the identification and diagnosis 
of children with FASD. Furthermore, the results of our survey 
support findings from other settings, suggesting that these 
issues are not unique to the UK health system.14 Indeed, many 
of the underlying reasons for this lack of consistency (eg lack of 
confidence in discussing a sensitive issue, rights of the indi-
vidual, and lack of a clear ‘gold standard’ to screen for alcohol 
use) are common globally.17
Clinical practices
Awareness and practices around alcohol screening were gener-
ally very encouraging. Most professions indicated that they 
proactively ask about alcohol consumption, and very few from 
each professional group had never referred a mother for alcohol 
or a child with FASD. A diverse range of alcohol screening 
tools were used, and the levels of alcohol consumption which 
triggered a referral varied considerably. This trend was observed 
across all professional groups. Further research into developing 
a standardised alcohol referral protocol specifically for preg-
nant women may support health professionals to provide a 
more consistent service.
An important indicator of the success, or otherwise, of cur-
rent clinical practice is the reported experiences of the women 
themselves. The Infant Feeding Survey 20109 asked women 
about the information they received in pregnancy regarding 
alcohol. Of the women who drank before pregnancy, 71% 
received information about drinking during pregnancy, and 
62% said they had been given general information about the 
effects of drinking alcohol on the baby. Only 36% stated they 
had been given information on how to cut down or limit the 
amount they drank during pregnancy, while just 29% said they 
had been given information on stopping drinking alcohol com-
pletely. When analysing the figures for those who received 
information about drinking, the most common source was a 
midwife (81%); 14% stated a health visitor, and 13% cited a 
doctor. In an Australian study, Crawford-Williams et  al,24 
highlighted the barriers identified by health professionals in 
discussing alcohol with women. They include the concepts that 
many professionals have a perception that most women do not 
drink in pregnancy; that women know not to drink; that alco-
hol is not a priority in a time-limited antenatal visit; and that 
discussing alcohol might cause anxiety, frighten, or anger the 
woman.24 These perceptions can be classified into determi-
nants such as self-efficacy, risk perception, and personal iden-
tity. The identification of specific barriers by the health 
professional increases self-awareness and is an important part 
of understanding what needs to be changed. Therefore, self-
reflection and awareness of differing and potentially conflict-
ing beliefs should be included in future training.
Referral pathways for patients with FASD varied widely, as 
there are no current NHS-coordinated FASD services estab-
lished in the United Kingdom to date.2 The lack of diagnostic 
clinics, interventions, and care pathways were reported as bar-
riers to referrals by GPs, paediatricians, and health visitors in 
particular. Until very recently, only one official diagnostic clinic 
in the United Kingdom was available and most FASD man-
agement resources are derived from Canadian or Australian 
practices.25 A lack of patient access to diagnostic services is well 
documented and will inevitably inhibit best practices of early 
intervention.17,26,27 To maintain the momentum of the 
informed and proactive health professionals, there is a clear 
need for the United Kingdom to launch standardised, high-
quality FASD services.
Knowledge. FASD training was a substantial need identified 
across all the professional groups surveyed. In particular, screen-
ing for FASD, alcohol use, and the onward referral processes 
were acknowledged as learning requirements. These findings 
corroborate empirical evidence and previous research which 
concluded that if FASD-related disorders (including second-
ary co-morbidities) are to be effectively prevented, identified, 
and treated, improvements to referral systems, professional 
education, and screening are essential for pregnant women and 
children with PAE.14,21 General practitioner responses espe-
cially reflected a desire for additional training. The relatively 
low levels of current FASD training in the United Kingdom 
are reflected in the low level of knowledge pertaining to FAS 
and FASD prevalence. In addition, the signs, symptoms, and 
diagnosis confidence levels were similarly low, with the excep-
tion of paediatricians. This identified knowledge gap may com-
promise the provision of care for mothers and children 
throughout the patient journey. Interestingly, health visitors, 
paediatricians, and GPs demonstrated relatively high levels of 
confidence in discussing FASD with patients. This is an inter-
esting finding for a group of professionals who otherwise report 
a lack of training in FASD and a limited knowledge base. This 
may be explained by the interpretation of the question in 
terms of professional competency rather than from an FASD-
specific perspective.
Identified gaps in FASD knowledge and awareness would 
support a link to the considerable under-diagnosis in the United 
Kingdom.21,22 Popova et al28 estimated an FASD prevalence rate 
of 5% based on an FAS prevalence rate in excess of 50 per 10 000 
of the general population. The latest figures from a large cohort 
prevalence study found that up to 17% of children screened posi-
tive for FASD but had not received a formal diagnosis.29
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In the United States, Gahagan et al27 surveyed 879 paedia-
tricians and found that 62% could identify children with 
FASD, 50% would diagnose a child who presented with 
FASD but only 34% would manage and coordinate treat-
ment. Similarly, Nevin et al26 surveyed 75 family physicians in 
Toronto and found that 8% had diagnosed a child with FAS 
and 17.9% had had suspicions but had not diagnosed. 
Confidence levels in FAS diagnosis were found to be low 
with 49% feeling that they had little confidence. Furthermore, 
only 60.8% reported advising pregnant women on alcohol 
consumption.
A little over half of the paediatricians had actually diagnosed 
FASD and over a third expressed concerns around stigmatisa-
tion of diagnosis. This suggests that the issue of stigma needs to 
be explored further in training packages to facilitate the diagno-
sis and management of children and adults with FASD. Stigma 
around alcohol use in pregnancy is an international issue. In 
Australia, Elliott et  al30 surveyed 132 paediatricians; 76.5% 
reported suspecting but not diagnosing FAS, 12.1% had been 
convinced but not diagnosed. The authors also report that of the 
same paediatricians, 79.6% agreed that early diagnosis may be 
beneficial, but 69.6% believed that diagnosis may be stigmatis-
ing, and furthermore, 36.4% presumed that parents might resist 
referral for assessment and intervention. Mukherjee et al13 also 
attributed the reluctance to diagnose FASD to professional lack 
of knowledge and stigma. Stigma is a serious concern for health 
professions. Corrigan et al31 confirmed that mothers of children 
with FASD are significantly stigmatised for their past behav-
iour and often experience public discrimination. To address this, 
Corrigan et al31 recommend contact-based strategies in prefer-
ence to educational strategies when implementing stigma 
reduction interventions.
Attitudes
Interestingly, professionals did not necessarily agree to routine 
blood or meconium screening even though they may facilitate 
the detection of foetal alcohol exposure. This may arise from an 
ethical and legal perspective as patient consent was not speci-
fied in the question. General practitioners and health visitors 
were the strongest supporters of screening initiatives. One pos-
sible explanation may be that children’s advocacy is a key role of 
the health visitor, but this is also true of the paediatricians who 
were more circumspect. To contextualise this matter, the NHS 
currently recommends offering routine antenatal screening of 
hepatitis B, HIV, and syphilis in every pregnancy.10 These tests 
arguably share similar issues of stigma and sensitivity as alcohol 
in pregnancy, but through training and a changing culture of 
practice, all have now become an accepted screening routine by 
women and health care professionals alike. Similarly, biomarker 
screening may benefit both the mother and child, and could be 
undertaken in a supportive manner which could direct valuable 
resources to those most in need.
Recommendations for practice. This study has identified a note-
worthy gap in knowledge around risks of PAE and the manage-
ment of children with FASD across the professions (Figure 3). 
This deficit will undoubtedly influence clinical practice and 
may partly explain the United Kingdom’s estimated high alco-
hol prevalence rates in pregnancy. It has also recognised clear 
FASD-related training needs which corroborate the conclu-
sions of Mukherjee et  al.13 While, acknowledging that some 
literature may not necessarily correlate increasing knowledge 
with behaviour change, we feel that education is the key facili-
tator available in this instance.32 Training will increase knowl-
edge and understanding, thus providing a rationale and catalyst 
for health care professionals to change attitudes to prevention, 
diagnosis, and early intervention. To support these initiatives 
and behaviour changes, the United Kingdom urgently requires 
clear, consistent, and mandated FASD referral pathways, 
guidelines, early interventions, and support services for chil-
dren and their families. This strategy should also include edu-
cation around the risks of harm from alcohol in pregnancy. 
Screening for alcohol should be routine in all primary-care set-
tings, with an emphasis on preconception health advice and 
contraceptive counselling. Referrals to established alcohol or 
substance misuse services for women identified to have an 
alcohol use disorder should also become the norm so that 
women receive the specialist support required. These initiatives 
could help to prevent further cases of FASD, and would mini-
mise co-morbidities and maximise the potential of individuals 
with FASD. A high-profile public health promotion to alert 
both health professionals and the general public to the risks of 
foetal alcohol exposure is overdue. Future research should seek 
to better understand FASD prevalence and characteristics of 
at-risk groups so that effective services and interventions can 
1. Comprehensive alcohol screening training across the key professions, including a focus on the issue of stigma.
2. A standardised antenatal alcohol screening tool
3. A national protocol for alcohol referrals including Brief Interventions
4. Universally accessible alcohol services across the UK with specialist pathways for pregnant women. 
5. A nationwide evidence-based professional training in FASD, screening and referrals which should also be included in 
the pre-registration curriculum. 
Figure 3. Recommendations for practice.
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be developed. A cost-benefit analysis of the impact of aware-
ness raising, training, screening, and referral on downstream 
costs to health and social care budgets should also be conducted 
to support the engagement of stakeholders at Government 
level. A Canadian study has referred to children with FASD as 
$1 million babies, but the prevention and management costs 
are likely to be a fraction of this.33
Strengths and limitations
We had originally planned to send our surveys to each relevant 
professional body for distribution across the United Kingdom. 
However, this approach was denied by all but the Institute of 
Health Visitors. We, therefore, asked local professional net-
works such as the North East and North Cumbria Clinical 
Research Network to circulate the questionnaires among all 
eligible health professionals locally and nationally. We requested 
all recipients to forward our survey link to other appropriate 
colleagues. This pragmatic approach increased the potential 
number of health professionals who received a questionnaire, 
but unfortunately left no clear audit trail. Consequently, we do 
not know the total number of health professionals who were 
invited to participate in the survey to calculate the response 
rate. Ideally in future studies, we would have profession-
specific questionnaires distributed from the corresponding 
professional governing bodies for maximum distribution.
Some health visitors responded to the paediatrician’s ques-
tionnaire, but we were able to identify them from the first 
question which asked about their speciality area. The data 
were then reassigned to the health visitor statistics. We are 
unable to comment on the generalisibility of our responders. 
Our results may be influenced by the inherent response bias of 
any survey questionnaire. The professionals who have an inter-
est in alcohol consumption in pregnancy and FASD may have 
been more likely to participate. This could have led to an over-
estimation of knowledge, attitudes, and practices in this sam-
ple. Social desirability bias may also confound self-reported 
opinions and practices. This may influence responses to sensi-
tive questions around as assessment and management, but the 
anonymity of this research should mitigate this bias. This 
exploratory study gives insight into the perceived knowledge, 
attitudes, and practices of five strategic NHS professions in 
relation to alcohol in pregnancy and FASD throughout 
childhood.
The generic limitations of questionnaires could also be 
applied to this study and include factors such as the truthful-
ness of responses, individual’s agendas, a lack of conscientious 
response and differences in understanding and interpretation. 
We also recognise that our findings are based on self-report 
and not a formal assessment of knowledge but still provide a 
useful insight.
Finally, due to the scope of this study, we were unable to 
examine individual’s detailed personal beliefs and perceptions, 
as many aspects of clinical practice that we asked about such as 
screening tools and referrals are guided by local protocols and 
resources. However, this topic would be worthy of future inves-
tigation and could include more qualitative methodologies 
such as interviews and focus groups.
Conclusions
This study highlights a need for training and education regard-
ing the risks of alcohol in pregnancy and FASD in children for 
health professionals in the United Kingdom. The health care 
infrastructure around FASD across the life course in the United 
Kingdom lags behind many Western countries such as USA, 
Canada, and Australia. However, we can learn from their expe-
rience and share the best practices already established on an 
international scale. If we are to prevent or minimise the risk of 
harm from PAE and make a significant difference to the out-
comes of individuals with FASD, we need to work collabora-
tively to expedite the establishment of world class FASD 
services throughout the United Kingdom.
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